Factors associated with an unsuppressed viral load among HIV-positive individuals attending STI services in South Africa, 2019

BMC Infect Dis. 2024 Jan 30;24(1):148. doi: 10.1186/s12879-023-08756-1.

Abstract

Background: Sexually transmitted infections (STIs), particularly in the absence of viral suppression, increase the risk of HIV transmission to uninfected partners. We determined factors associated with having an unsuppressed VL among HIV-positive individuals attending STI services in South Africa (SA).

Methods: We analysed secondary cross-sectional data collected on HIV-positive individuals presenting with STI symptoms s at sentinel sites in Western Cape and Gauteng provinces between January-December 2019 in SA. We compared demographic characteristics of individuals on ART or not on ART, and a Poisson regression model to identify factors associated with having an unsuppressed VL (≥ 50 copies/ml) was used.

Results: Among 93 HIV-positive individuals attending STI services with VL data, the median age was 32 years (IQR 27-37). Thirty-two (34.41%) individuals were on ART compared to 61 (65.59%) not on ART. Most of those on ART (56.25%) had an unsuppressed VL, while 86.89% of those not on ART had an unsuppressed VL. ART use was associated with a 33% lower prevalence of having unsuppressed VL. In a model adjusting for age, age at first sex and oral sex, none of the factors were significant. Among those on ART, individuals < 25 years were more likely to have an unsuppressed VL (aPRR = 1.94: 95% CI = 1.27-2.97) compared to those ≥ 25 years.

Conclusion: ART use among HIV-positive individuals was low and VL suppression among those on ART was sub-optimal. Intensified ART initiation and adherence support to HIV-positive individuals seeking STI services could improve VL suppression.

Keywords: 95–95-95; Antiretroviral therapy; HIV; Sexually Transmitted Infections; South Africa; VL; VL suppression.

MeSH terms

  • Adult
  • Anti-HIV Agents* / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • Cross-Sectional Studies
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • Humans
  • Sexually Transmitted Diseases* / epidemiology
  • South Africa / epidemiology
  • Viral Load

Substances

  • Anti-Retroviral Agents
  • Anti-HIV Agents